It has also been further demonstrated that in HSCs, retinol release is dysregulated by PNPLA3 148M, which further enables excessive hepatic fibrosis in the context of NASH [10]. Here, PNPLA3 is linked to metabolic dysfunction-associated steatohepatitis.